Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension

NCT00553267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

947

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: fixed dose combination of telmisartan+amlodipine
DRUG: amlodipine

Sponsor

Boehringer Ingelheim